InsiderFlow

BCAX

Bicara Therapeutics Inc. Common Stock$17.94-0.88 (-4.68%)
Prev Close$18.79·MCap$1.07B·P/E3.57·Vol230.0K·Yield

Buys (12M)

1

$4.80M

Sells (12M)

27

$7.57M

Net Activity

Net Seller

$2.77M

Active Insiders

6

last 12 mo

Over the past 12 months, insider activity at Bicara Therapeutics Inc. Common Stock (BCAX) has been mixed between buying and selling, with 1 insider purchase totaling $4.80M and 27 insider sales totaling $7.57M. The most recent insider transaction was by Mazumdar Claire (director, officer: Chief Executive Officer), who sold $282.4K worth of shares on Mar 20, 2026. Bicara Therapeutics Inc. Common Stock operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $1.07B.

BCAX Insider Trading Activity

DateInsiderTypeValue
Mar 20, 2026 Mazumdar ClaireSell$282.4K
Mar 6, 2026 Mazumdar ClaireSell$154.3K
Mar 5, 2026 Cohlhepp RyanSell$315.9K
Mar 5, 2026 Hyep IvanSell$301.0K
Mar 5, 2026 Raben DavidSell$305.6K
Mar 2, 2026 RA CAPITAL MANAGEMENT, L.P.Buy$4.80M
Feb 27, 2026 Cohlhepp RyanSell$65.5K
Jan 26, 2026 Cohlhepp RyanSell$69.3K
Jan 26, 2026 Hyep IvanSell$34.2K
Jan 22, 2026 Cohlhepp RyanSell$69.3K
Jan 22, 2026 Hyep IvanSell$34.2K
Jan 15, 2026 Cohlhepp RyanSell$2.7K
Dec 22, 2025 Hyep IvanSell$168.5K
Dec 15, 2025 Cohlhepp RyanSell$233.5K
Nov 24, 2025 Mazumdar ClaireSell$776.4K
Nov 24, 2025 Raben DavidSell$205.1K
Nov 21, 2025 Cohlhepp RyanSell$225.6K
Nov 21, 2025 Hyep IvanSell$341.1K
Oct 16, 2025 Mazumdar ClaireSell$453.8K
Oct 15, 2025 Cohlhepp RyanSell$226.9K
Oct 13, 2025 Mazumdar ClaireSell$466.9K
Oct 9, 2025 Hyep IvanSell$116.9K
Oct 9, 2025 Raben DavidSell$405.9K
Oct 6, 2025 Cohlhepp RyanSell$911.8K
Oct 6, 2025 Hyep IvanSell$553.2K
Sep 29, 2025 Meisner LaraSell$498.7K
Sep 15, 2025 Meisner LaraSell$181.9K
Jun 16, 2025 Meisner LaraSell$165.1K
Mar 14, 2025 Meisner LaraSell$1.02M
Sep 17, 2024 Flynn James EBuy$630.0K

BCAX Insider Buying Activity

The following table shows recent insider purchases of Bicara Therapeutics Inc. Common Stock (BCAX) stock reported via SEC Form 4 filings.

DateInsiderTypeValue
Mar 2, 2026 RA CAPITAL MANAGEMENT, L.P.Buy$4.80M
Sep 17, 2024 Flynn James EBuy$630.0K

BCAX Insider Selling Activity

The following table shows recent insider sales of Bicara Therapeutics Inc. Common Stock (BCAX) stock reported via SEC Form 4 filings.

DateInsiderTypeValue
Mar 20, 2026 Mazumdar ClaireSell$282.4K
Mar 6, 2026 Mazumdar ClaireSell$154.3K
Mar 5, 2026 Cohlhepp RyanSell$315.9K
Mar 5, 2026 Hyep IvanSell$301.0K
Mar 5, 2026 Raben DavidSell$305.6K
Feb 27, 2026 Cohlhepp RyanSell$65.5K
Jan 26, 2026 Cohlhepp RyanSell$69.3K
Jan 26, 2026 Hyep IvanSell$34.2K
Jan 22, 2026 Cohlhepp RyanSell$69.3K
Jan 22, 2026 Hyep IvanSell$34.2K
Jan 15, 2026 Cohlhepp RyanSell$2.7K
Dec 22, 2025 Hyep IvanSell$168.5K
Dec 15, 2025 Cohlhepp RyanSell$233.5K
Nov 24, 2025 Mazumdar ClaireSell$776.4K
Nov 24, 2025 Raben DavidSell$205.1K
Nov 21, 2025 Cohlhepp RyanSell$225.6K
Nov 21, 2025 Hyep IvanSell$341.1K
Oct 16, 2025 Mazumdar ClaireSell$453.8K
Oct 15, 2025 Cohlhepp RyanSell$226.9K
Oct 13, 2025 Mazumdar ClaireSell$466.9K
Oct 9, 2025 Hyep IvanSell$116.9K
Oct 9, 2025 Raben DavidSell$405.9K
Oct 6, 2025 Cohlhepp RyanSell$911.8K
Oct 6, 2025 Hyep IvanSell$553.2K
Sep 29, 2025 Meisner LaraSell$498.7K
Sep 15, 2025 Meisner LaraSell$181.9K
Jun 16, 2025 Meisner LaraSell$165.1K
Mar 14, 2025 Meisner LaraSell$1.02M

BCAX Insiders

Mazumdar Claire

director, officer: Chief Executive Officer

Sold $2.13M
5 tradesLast: Mar 20, 2026
Cohlhepp Ryan

President and COO

Sold $2.12M
9 tradesLast: Mar 5, 2026
Hyep Ivan

officer: Chief Financial Officer

Sold $1.55M
7 tradesLast: Mar 5, 2026
Raben David

officer: Chief Medical Officer

Sold $916.6K
3 tradesLast: Mar 5, 2026
RA CAPITAL MANAGEMENT, L.P.

director, 10 percent owner:

Bought $4.80M
1 tradesLast: Mar 2, 2026
Meisner Lara

Chief Legal Officer

Sold $1.87M
4 tradesLast: Sep 29, 2025
Flynn James E

10% Owner

Bought $630.0K
1 tradesLast: Sep 17, 2024